These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12385590)

  • 1. Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate.
    Pistevou-Gombaki K; Eleftheriadis N; Sofroniadis I; Makris P; Kouloulias V
    J Exp Clin Cancer Res; 2002 Sep; 21(3):429-32. PubMed ID: 12385590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of disodium pamidronate in the management of bone pain due to malignancy.
    Groff L; Zecca E; De Conno F; Brunelli C; Boffi R; Panzeri C; Cazzaniga M; Ripamonti C
    Palliat Med; 2001 Jul; 15(4):297-307. PubMed ID: 12054147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.
    Wang RF; Zhang CL; Zhu SL; Zhu M
    Med Princ Pract; 2003; 12(2):97-101. PubMed ID: 12634464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
    Glover D; Lipton A; Keller A; Miller AA; Browning S; Fram RJ; George S; Zelenakas K; Macerata RS; Seaman JJ
    Cancer; 1994 Dec; 74(11):2949-55. PubMed ID: 7525038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
    Small EJ; Smith MR; Seaman JJ; Petrone S; Kowalski MO
    J Clin Oncol; 2003 Dec; 21(23):4277-84. PubMed ID: 14581438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.
    Cascinu S; Casadei V; Del Ferro E; Alessandroni P; Catalano G
    Support Care Cancer; 1996 Jan; 4(1):31-3. PubMed ID: 8771291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of disodium pamidronate in patients with bone metastases in patients with pulmonary carcinoma].
    Ranković B; Mrdja V
    Vojnosanit Pregl; 2002; 59(1):33-6. PubMed ID: 11928188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pamidronate in the management of bone metastases from breast cancer: results of a non-comparative multicenter phase II trial. Aredia Multinational Cooperative Group.
    Tyrrell CJ
    Ann Oncol; 1994; 5 Suppl 7():S37-40. PubMed ID: 7532992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.
    Conte PF; Giannessi PG; Latreille J; Mauriac L; Koliren L; Calabresi F; Ford JM
    Ann Oncol; 1994; 5 Suppl 7():S41-4. PubMed ID: 7873461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous pamidronate for metastatic bone pain.
    Purohit OP; Anthony C; Radstone CR; Owen J; Coleman RE
    Br J Cancer; 1994 Sep; 70(3):554-8. PubMed ID: 8080746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancer.
    Tyrrell CT; Bruning PF; May-Levin F; Rose C; Mauriac L; Soukop M; Ford JM
    Eur J Cancer; 1995 Nov; 31A(12):1976-80. PubMed ID: 8562151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and feasibility evaluation in long term pamidronate treatment of bone metastases].
    Senkus-Konefka E; Krasińska L; Pikiel J; Krasińska W; Nowaczyk M; Jassem J
    Przegl Lek; 2003; 60(7):467-70. PubMed ID: 14750420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of image processing techniques to assess effect of disodium pamidronate in conjunction with radiotherapy in patients with bone metastases.
    Kouloulias VE; Dardoufas CE; Kouvaris JR; Antypas CE; Sandilos PH; Matsopoulos GK; Vlahos LJ
    Acta Oncol; 2002; 41(2):169-74. PubMed ID: 12102162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer.
    Lipton A; Glover D; Harvey H; Grabelsky S; Zelenakas K; Macerata R; Seaman J
    Ann Oncol; 1994; 5 Suppl 7():S31-5. PubMed ID: 7532991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.
    Vitale G; Fonderico F; Martignetti A; Caraglia M; Ciccarelli A; Nuzzo V; Abbruzzese A; Lupoli G
    Br J Cancer; 2001 Jun; 84(12):1586-90. PubMed ID: 11401309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
    N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
    Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
    Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intra-patient dose-escalation study of disodium pamidronate plus radiotherapy versus radiotherapy alone for the treatment of osteolytic metastases. Monitoring of recalcification using image-processing techniques.
    Kouloulias EV; Kouvaris RJ; Antypas C; Mystakidou K; Matsopoulos G; Uzunoglu CN; Moulopoulos A; Vlahos JL
    Strahlenther Onkol; 2003 Jul; 179(7):471-9. PubMed ID: 12835884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.
    Hultborn R; Gundersen S; Ryden S; Holmberg E; Carstensen J; Wallgren UB; Killany S; Andreassen L; Carlsson G; Fahl N; Hatschek T; Sommer HH; Hessman Y; Hornmark-Stenstam B; Johnsborg S; Klepp R; Laino R; Niklasson LG; Rudenstam CM; Sundbeck A; Söderberg M; Tejler G
    Anticancer Res; 1999; 19(4C):3383-92. PubMed ID: 10629624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative treatment of bone metastases in hormone-refractory prostate cancer: effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels.
    Kawashima H; Tanaka T; Kuratsukuri K; Uchida J; Sugimura K; Tamada S; Nishisaka N; Kumata K; Iwai Y; Ikemoto S; Ezaki K; Nakatani T
    Urol Int; 2007; 78(4):345-50. PubMed ID: 17495494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.